High-growth diabetes company Diabeloop closes its Series C financing round – led by LBO France, joined by Terumo Corporation, Innovacom and backed by Diabeloop’s historical partners – to power the company’s commercial roll-out and global expansion.
High-growth diabetes company Diabeloop closes its Series C financing round – led by LBO France, joined by Terumo Corporation, Innovacom and backed by Diabeloop’s historical partners – to power the company’s commercial roll-out and global expansion.